For an 85-year-old patient with severe systolic heart failure (ejection fraction 15%) and a documented do‑not‑intubate order who is now hypoxic, and whose healthcare proxy insists on intubation, what is the next best step?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Do Not Intubate

The next best step is d) do not intubate. The patient has a documented do-not-intubate (DNI) order that must be honored regardless of the healthcare proxy's current request 1, 2.

Legal and Ethical Framework

A valid advance directive—including a DNI order—represents the patient's autonomous decision made when they had decision-making capacity. This directive remains binding even when a healthcare proxy requests contradictory interventions 1, 2. The healthcare proxy's role is to advocate for what the patient would have wanted, not to override the patient's explicitly stated wishes.

The ACC/AHA guidelines explicitly classify aggressive procedures including intubation in NYHA functional class IV heart failure patients (which this patient clearly represents with an EF of 15% and acute decompensation) as Class III: Not Appropriate when patients are "not anticipated to experience clinical improvement from available treatments" 1, 2.

Clinical Context Supporting the DNI Order

This 85-year-old patient with:

  • Severe systolic heart failure (EF 15%)
  • Acute pulmonary edema with bilateral crackles throughout all lung fields
  • Hypoxemia (80% on non-rebreather) with confusion
  • Pre-existing DNI order

represents end-stage heart failure with extremely poor prognosis. Intubation in this setting would likely only prolong suffering without meaningful recovery 1. The guidelines emphasize that intubation carries substantial risks including ventilator-associated complications, ICU-acquired weakness, and hemodynamic compromise 3—risks that are magnified in patients with severely compromised cardiac function.

Immediate Management Steps

Instead of intubation, focus on:

  1. Aggressive medical management: IV diuretics (loop diuretics), IV vasodilators (nitroglycerin starting at 0.25 μg/kg/min) to reduce preload and afterload 4

  2. Non-invasive ventilation: Consider CPAP or BiPAP, which can obviate intubation in up to 75% of acute heart failure cases with pulmonary edema 4. This respects the DNI order while providing respiratory support

  3. Symptom management: Opioids for dyspnea, anxiolytics for distress 5, 6

  4. Communication with the healthcare proxy: Have an urgent, empathetic discussion explaining:

    • The patient's documented wishes through the DNI order
    • The poor prognosis with EF 15% and acute decompensation
    • That intubation would not align with the patient's stated goals of care
    • Alternative comfort measures being provided

Common Pitfall to Avoid

Do not allow the proxy's emotional distress to override the patient's documented autonomous decision. The proxy may be acting from grief, fear, or guilt rather than representing the patient's true wishes. The physician's duty is to the patient's expressed preferences, not to family demands that contradict those preferences 1, 2.

The options of court orders (b) or legal team consultation (e) are unnecessary and would cause harmful delays. Psychiatry consultation (c) is irrelevant—the patient made this decision when they had capacity, and their current confusion doesn't invalidate their prior advance directive.

Honor the DNI order, provide aggressive comfort-focused medical management including non-invasive ventilation if appropriate, and compassionately counsel the healthcare proxy about respecting the patient's documented wishes.

Related Questions

What is the best approach for intubation and mechanical ventilation in a hypotensive and hypoxemic patient with pulmonary edema in the ICU?
What is the appropriate immediate management for a 65-year-old woman with dyspnea, severe hypoxemia (SpO₂ 66% on high‑flow oxygen at 7 L/min), bradycardia (heart rate 60 bpm), who has received a cardiac arrest loading dose and 4 mL furosemide?
What is the appropriate outpatient treatment plan for a 73-year-old woman with hypertension and dyspnea on exertion who has an echocardiogram showing normal ejection fraction and grade 1 diastolic dysfunction, and is currently taking hydrochlorothiazide 25 mg and olmesartan 20 mg daily?
In a 58-year-old patient presenting with progressive dyspnea and paroxysmal nocturnal dyspnea, whose echocardiogram shows anterior wall hypokinesia and a left ventricular ejection fraction of 30%, what is the next best investigation?
What is the best course of action for a 57-year-old male with a history of congestive heart failure (CHF), coronary artery disease (CAD), hypertension (HTN), and chronic kidney disease (CKD) stage III, presenting with shortness of breath (SOB) and chest pain, who is a smoker and has been using home oxygen as needed?
If I take vitamin D supplementation for low vitamin D while having normal calcium levels, will it cause hypercalcemia?
How should an elderly, thin female patient presenting with small‑bowel obstruction and medial thigh pain due to an obturator hernia be managed?
In an elderly patient with recent Enterococcus faecalis urinary tract infection, bacteremia, and endocarditis, a 4 mm aortic bioprosthetic valve opacity, now presenting with painful palpable purpura that has progressed to bullae and new transaminitis while on daptomycin, who previously received intravenous ampicillin and ceftriaxone (Rocephin) and has a history of transcatheter aortic valve replacement (TAVR) with pacemaker, atrial fibrillation on apixaban (Eliquis), and daily furosemide with as‑needed potassium supplementation, how should I work up and manage the suspected drug‑induced bullous leukocytoclastic vasculitis versus other vasculitic etiologies from a pharmacy standpoint?
How should Curasept (0.12% chlorhexidine gluconate) mouthwash be used, including dosage, frequency, duration, and contraindications?
How should a patient with second-degree atrioventricular (AV) block Mobitz type II be managed?
In a patient with an ischemic stroke secondary to non‑valvular atrial fibrillation, should an antiplatelet agent be added to oral anticoagulation therapy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.